Aoki Y, Yanagisawa Y, Oguchi H, Furuta S
Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Diabetes Res Clin Pract. 1991 Nov;14(2):85-9. doi: 10.1016/0168-8227(91)90113-r.
The variation of urinary C-peptide clearance in relation to hyperglycemia and renal damage was evaluated in 57 patients with non-insulin-dependent diabetes mellitus (NIDDM) with and without overt proteinuria, 14 nondiabetic patients with renal disease (RD) and 18 healthy control subjects. Urinary C-peptide clearance expressed as the ratio of urinary C-peptide to creatinine clearance (CCP/CCR) in the fasting state did not differ in control subjects and RD patients, and was higher equally in NIDDM patients with and without proteinuria. In NIDDM patients without overt proteinuria, urinary levels of C-peptide, beta 2-microglobulin (B2M), N-acetyl-beta-D-glucosaminidase (NAG) and albumin as well as CCP/CCR ratio all decreased significantly with short-term glycemic control (P less than 0.05). Despite a wide range of CCP/CCR ratio (0.07-0.73), a weak but significant correlation (r = 0.56, P less than 0.005) was found between fasting serum and urinary C-peptide levels in NIDDM patients. These results suggest that urinary C-peptide may easily be affected by hyperglycemia per se rather than renal damage, while urinary B2M, NAG and albumin may be affected by both hyperglycemia and renal damage. When the urinary C-peptide level is interpreted, the influence of hyperglycemia on it must be taken into consideration.
在57例非胰岛素依赖型糖尿病(NIDDM)患者(有或无显性蛋白尿)、14例患有肾脏疾病(RD)的非糖尿病患者及18名健康对照者中,评估了尿C肽清除率与高血糖及肾损害的关系。空腹状态下,以尿C肽与肌酐清除率之比(CCP/CCR)表示的尿C肽清除率在对照者和RD患者中无差异,在有和无蛋白尿的NIDDM患者中同样较高。在无显性蛋白尿的NIDDM患者中,随着短期血糖控制,尿C肽、β2-微球蛋白(B2M)、N-乙酰-β-D-氨基葡萄糖苷酶(NAG)及白蛋白水平以及CCP/CCR比值均显著下降(P<0.05)。尽管CCP/CCR比值范围较宽(0.07 - 0.73),但在NIDDM患者中,空腹血清和尿C肽水平之间仍存在微弱但显著的相关性(r = 0.56,P<0.005)。这些结果表明,尿C肽可能更容易受高血糖本身影响而非肾损害,而尿B2M、NAG和白蛋白可能受高血糖和肾损害两者影响。在解释尿C肽水平时,必须考虑高血糖对其的影响。